About this Medicine article
Female Patients Suffering from Inflammatory Bowel Diseases Are Treated Less Frequently with Immunosuppressive Medication and Have a Higher Disease Activity by I. Blumenstein; E. Herrmann; N. Filmann; C. Zosel; W. Tacke; H. Bock; A. Dignaß; F. Hartmann; S. Zeuzem; J. Stein; O. Schröder is a Medicine article available to read on EtoBox.
Background: The introduction of immunosuppressants and biologic agents has led to active debate and research about optimal therapeutic strategies considering risk factors and predictors of clinical outcome in inflammatory bowel disease (IBD). Data about gender-specific treatment differences and risk factors is lacking for IBD. The aim of the present study was to evaluate gender-related differences in the treatment of a distinct IBD patient population treated in the Rhein-Main region, Germany. Methods: Data about past medical history, disease status and medical treatment of 986 outpatients treated in ten gastroenterological practices and three hospitals were collected from November 1st 2005-July 31st 2007 and analyzed with regard to gender-related differences in therapy and disease management.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- I. Blumenstein; E. Herrmann; N. Filmann; C. Zosel; W. Tacke; H. Bock; A. Dignaß; F. Hartmann; S. Zeuzem; J. Stein; O. Schröder
- Publisher
- Oxford University Press (OUP)
- Published
- 2011
- Language
- EN
- Field
- Medicine (Health Sciences)